The Sunrest Lifescience IPO commenced on November 7, 2023, and concluded on November 9, 2023. The allotment of shares took place on November 15, 2023, and the initiation of refunds began on November 16, 2023. The shares were credited to the demat accounts of investors on November 17, 2023. Finally, the listing of Sunrest Lifescience on the stock exchange occurred on November 20, 2023.
The Sunrest Lifescience IPO was priced at ₹84 per share, with a lot size of 1600 shares. The total issue size was ₹10.85 crores, comprising a fresh issue of ₹10.85 crores. The IPO was listed on the NSE SME.
In terms of quota reservations, the other quota was reserved for 50% of the shares and the retail quota was reserved for 50% of the shares.
Sunrest Lifescience IPO Basic Details
|Company Name||Sunrest Lifescience Limited|
|Domain of Company||Healthcare and Personal Care|
|Sunrest Lifescience IPO GMP Today||₹13|
|Sunrest Lifescience IPO Listing Gain||15.48%|
|Sunrest Lifescience IPO Open Date||November 7, 2023|
|Sunrest Lifescience IPO Close Date||November 9, 2023|
|Sunrest Lifescience IPO Allotment Date||November 15, 2023|
|Sunrest Lifescience IPO Listing Date||November 20, 2023|
|Face Value||₹10 per share|
|Price||₹84 per share|
|Lot Size||1600 Shares|
|Issue Size||1,291,200 shares of ₹10|
(aggregating up to ₹10.85 Cr)
|Fresh Issue||1,291,200 shares of ₹10|
(aggregating up to ₹10.85 Cr)
|Issue Type||Fixed Price Issue IPO|
|Listing At||NSE SME|
|Company Promoters||Mr. Nikhilkumar Y Thakkar,|
Mr. Amitbhai Shambhulal Thakkar,
Mr. Bhagyesh Kiritbhai Parekh and
Mr. Bharatkumar V Thakkar
Sunrest Lifescience IPO GMP Today:
|Date||GMP||Listing Gain||Kostak||Subject to|
|5 November 2023||₹13||15.48%||–||–|
Sunrest Lifescience Limited IPO Details:
Sunrest Lifescience Limited started in 2017 and offers a wide variety of healthcare and personal care products. Their product range includes items like Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. They provide various types of medications, such as those for bacterial infections, diarrhea, fungal issues, malaria, diabetes, dental care, allergies, high blood pressure, cosmetics, parasites, vitamins, minerals, nutrition, and inflammation.
The company doesn’t make these products themselves; they have other pharma manufacturers, including Trilend Pharmaceuticals Private Limited (Trilend), a company within the Sunrest group, make them. Sunrest Lifescience works with 43 third-party manufacturers in different states like Gujarat, Punjab, Maharashtra, Haryana, Himachal Pradesh, Uttarakhand, and Madhya Pradesh.
Their products are distributed to stockists and super stockists and can be found in places like chemist shops, dispensaries, and hospitals. They take pride in their 18 registered trademarks for 32 products, showing their dedication to providing top-quality products to their customers.
Sunrest Lifescience IPO More Details Click Here
Sunrest Lifescience IPO FAQs
When is Sunrest Lifescience IPO open?
Sunrest Lifescience IPO will open on 7 November 2023.
When is Sunrest Lifescience IPO Close?
Sunrest Lifescience IPO will be closed on 9 November 2023.
What is Sunrest Lifescience IPO GMP Today?
The Sunrest Lifescience IPO GMP aka Grey Market Premium is ₹13.
What is Sunrest Lifescience IPO Kostak Rates Today?
The Sunrest Lifescience IPO Kostak Rate is ₹000.
What is Sunrest Lifescience IPO Subject to Sauda Price Today?
The Sunrest Lifescience IPO subject to sauda rates is ₹000.
Sunrest Lifescience IPO Expected Returns?
The Sunrest Lifescience expected return is 15.48%.
How much will be the listing gain in Sunrest Lifescience IPO?
Sunrest Lifescience IPO will get listing gain of 15.48%. (Approx.)